Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissions

Summary by The Globe & Mail
Number of biosimilar submissions increased more than 400% from 2016 to 2025, while departmental resources remained ‘relatively constant’

1 Articles

The Globe & MailThe Globe & Mail
Center

Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissions

Number of biosimilar submissions increased more than 400% from 2016 to 2025, while departmental resources remained ‘relatively constant’

·Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Globe & Mail broke the news in Canada on Thursday, September 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Health Canada icon

Health Canada

Toronto, ON icon

Toronto, ON

News
For You
SearchBlindspotLocal